Back to Search
Start Over
Photobiomodulation (low-level light therapy) and dry eye disease
- Source :
- Clinicalexperimental optometry. 104(5)
- Publication Year :
- 2021
-
Abstract
- Dry eye disease is one of the most common, chief-complaints presenting in clinical practice, with a prevalence of up to 50%. Evaporative dry eye, as a result of meibomian gland dysfunction, is thought to be the biggest component factor. Treatments for meibomian gland dysfunction aim to restore tear film homoeostasis and include warm compress therapy, eyelid hygiene, in-office meibomian gland expression and lipid-containing, artificial tears. A recent introduction to the in-office treatments available for meibomian gland dysfunction has been low-level light therapy, also known as photobiomodulation. The technique involves applying red, or near infra-red, radiation using low-power light sources and is suggested to promote tissue repair, decrease inflammation, and relieve pain. This work aims to review the available literature on the efficacy and safety of photobiomodulation in meibomian gland dysfunction and dry eye disease, as well as what is currently known about its mechanism of action.
- Subjects :
- Light therapy
medicine.medical_specialty
medicine.medical_treatment
Meibomian gland
Disease
03 medical and health sciences
0302 clinical medicine
Low-Level Light Therapy
Medicine
Humans
Meibomian Gland Dysfunction
integumentary system
business.industry
Meibomian gland dysfunction
Meibomian Glands
Dermatology
body regions
Clinical Practice
Ophthalmology
Artificial tears
medicine.anatomical_structure
Tears
030221 ophthalmology & optometry
Eyelid Diseases
Dry Eye Syndromes
sense organs
Eyelid
business
030217 neurology & neurosurgery
Optometry
Subjects
Details
- ISSN :
- 14440938
- Volume :
- 104
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Clinicalexperimental optometry
- Accession number :
- edsair.doi.dedup.....77683fc6f513b1d797a13d885c37d8bb